Riskpilot← Back to searchSign inGet full accessOptalmica Holding AB
ABActiveOrg 5591780522Stora Marknadsvägen 15 Ing.K3 TäbycActivities of holding companies · NACE 6421Est. 20180 employees
Revenue 2025
SEK 1
EBITDA margin
-2425600.0%
+70% vs 2024
Equity ratio
49.5%
Financial strength
Net profit 2025
SEK 7,1M
-18% vs 2024
| Revenue | SEK 1 | — |
| EBITDA | SEK -24K | +70% |
| Net profit | SEK 7,1M | -18% |
| Total assets | SEK 27,9M | +0% |
| Equity | SEK 13,8M | -10% |
| Employees | 0 | — |
Legal name
Optalmica Holding AB
Org number
5591780522
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
1 november 2018
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är att äga och förvalta aktier samt därmed förenlig verksamhet.
Address
Stora Marknadsvägen 15 Ing.K3 Täbyc
Email
malin.westerberg@optalmica.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −39 | −33 | −101 | −80 | −24 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −39 | −33 | −101 | −80 | −24 |
| Net financials | 5 420 | 8 724 | 66 | 76 | 267 |
| Profit before tax | 5 432 | 13 925 | −34 | 10 916 | 9 017 |
| Tax | −0 | −1 076 | −0 | −2 262 | −1 879 |
| Net profit | 5 432 | 12 849 | −34 | 8 654 | 7 138 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8 578 | 21 115 | 19 863 | 27 849 | 27 943 |
| Equity | 8 545 | 17 120 | 12 494 | 15 338 | 13 829 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 33 | 2 265 | 5 639 | 7 121 | 5 693 |
| Total debt | 33 | 2 265 | 5 639 | 7 121 | 5 693 |
EBITDA margin
-2425600.0%
This company
15.8%
Market median
-15351999% vs market
20212025
Equity ratio
49.5%
This company
38.2%
Market median
+30% vs market
20212025
Return on equity
51.6%
This company
18.4%
Market median
+180% vs market
20212025
Net profit margin
713848300.0%
This company
8.1%
Market median
+8812941875% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EM Chief Executive Officer | Chief Executive Officer | 2020 |
JR Audit | Audit | 2022 |
| Former (1) | ||
LL Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Optalmica Holding AB (this company)
Oftalmus Läkarkonsult ABBoard members of Optalmica Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Ludwig Holmgren | Chief Auditor | 0 companies |
| Eva Malin Westerberg | Chief Executive Officer | 0 companies |
| Jens Roland Brehme | Audit | 0 companies |
| Zoi Papaioannou | Deputy Board Member | 0 companies |
| Nikolaos Merkoudis | Chairman | 0 companies |